Adial Pharmaceuticals, Inc. Common Stock, Value, Issued
Adial Pharmaceuticals, Inc. (ADIL) had Common Stock, Value, Issued of $3.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-14
- 2026-06-30: Common Stock, Value, Issued $3.00K.
- 2026-03-31: Common Stock, Value, Issued $1.51K.
- 2025-12-31: Common Stock, Value, Issued $1.00K; Common Stock, Value, Issued as first filed $1.11K.
- 2025-09-30: Common Stock, Value, Issued $23.84K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $3.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.51K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.00K 10-Q · filed 2026-08-14 | $1.11K 10-K · filed 2026-03-05 |
| 2025-09-30 | $23.84K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $21.54K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $6.65K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $259.00 10-K · filed 2026-03-05 | $6.47K 10-K · filed 2025-03-04 |
| 2024-09-30 | $6.40K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $4.29K 10-Q · filed 2024-08-13 | |
| 2023-12-31 | $1.66K 10-K · filed 2025-03-04 | |
| 2023-09-30 | $1.22K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.20K 10-Q/A · filed 2023-10-30 | |
| 2023-03-31 | $28.52K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.07K 10-K · filed 2024-04-01 | $26.69K 10-K · filed 2023-03-30 |
| 2022-09-30 | $26.85K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $25.85K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $23.72K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $20.95K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $20.45K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $18.41K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $17.27K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $14.39K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $14.22K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $13.45K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $10.63K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $10.37K 10-K · filed 2021-03-22 | |
| 2019-09-30 | $10.29K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $10.24K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $10.17K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $6.86K 10-K · filed 2020-03-20 | |
| 2018-09-30 | $6.56K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $3.56K 10-Q · filed 2018-09-10 | |
| 2017-12-31 | $3.27K 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |